AU2005306575A1 - Improved nutraceutical composition - Google Patents
Improved nutraceutical composition Download PDFInfo
- Publication number
- AU2005306575A1 AU2005306575A1 AU2005306575A AU2005306575A AU2005306575A1 AU 2005306575 A1 AU2005306575 A1 AU 2005306575A1 AU 2005306575 A AU2005306575 A AU 2005306575A AU 2005306575 A AU2005306575 A AU 2005306575A AU 2005306575 A1 AU2005306575 A1 AU 2005306575A1
- Authority
- AU
- Australia
- Prior art keywords
- phytonutrient
- nutritional
- composition according
- nutraceutical
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims description 168
- 239000002417 nutraceutical Substances 0.000 title claims description 84
- 235000021436 nutraceutical agent Nutrition 0.000 title claims description 84
- 235000013305 food Nutrition 0.000 claims description 100
- 235000016709 nutrition Nutrition 0.000 claims description 70
- 239000000284 extract Substances 0.000 claims description 42
- -1 dichalcones Chemical class 0.000 claims description 41
- 235000021466 carotenoid Nutrition 0.000 claims description 39
- 238000000034 method Methods 0.000 claims description 38
- 239000000126 substance Substances 0.000 claims description 38
- 235000021281 monounsaturated fatty acids Nutrition 0.000 claims description 33
- 241000196324 Embryophyta Species 0.000 claims description 32
- 239000002537 cosmetic Substances 0.000 claims description 31
- 235000013311 vegetables Nutrition 0.000 claims description 28
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 claims description 25
- 235000011957 flavonols Nutrition 0.000 claims description 25
- 241000234282 Allium Species 0.000 claims description 22
- 239000011648 beta-carotene Substances 0.000 claims description 22
- 235000013734 beta-carotene Nutrition 0.000 claims description 21
- 235000012041 food component Nutrition 0.000 claims description 19
- 241000220225 Malus Species 0.000 claims description 18
- 235000011430 Malus pumila Nutrition 0.000 claims description 18
- 235000015103 Malus silvestris Nutrition 0.000 claims description 18
- 229930003944 flavone Natural products 0.000 claims description 18
- 235000011949 flavones Nutrition 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 17
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 14
- 201000010099 disease Diseases 0.000 claims description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 14
- 150000002213 flavones Chemical class 0.000 claims description 14
- 229930195733 hydrocarbon Natural products 0.000 claims description 14
- 230000000694 effects Effects 0.000 claims description 13
- 150000002216 flavonol derivatives Chemical class 0.000 claims description 13
- 239000008157 edible vegetable oil Substances 0.000 claims description 11
- 235000005254 Allium ampeloprasum Nutrition 0.000 claims description 10
- 240000006108 Allium ampeloprasum Species 0.000 claims description 10
- 240000002234 Allium sativum Species 0.000 claims description 10
- 239000004215 Carbon black (E152) Substances 0.000 claims description 10
- 206010028980 Neoplasm Diseases 0.000 claims description 10
- 229930014669 anthocyanidin Natural products 0.000 claims description 10
- 235000008758 anthocyanidins Nutrition 0.000 claims description 10
- 201000011510 cancer Diseases 0.000 claims description 10
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 claims description 10
- 235000004611 garlic Nutrition 0.000 claims description 10
- 125000004383 glucosinolate group Chemical group 0.000 claims description 10
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 10
- 235000008696 isoflavones Nutrition 0.000 claims description 10
- 241001677259 Acanthophoenix rubra Species 0.000 claims description 9
- 235000019482 Palm oil Nutrition 0.000 claims description 9
- 229930003949 flavanone Natural products 0.000 claims description 9
- 150000002208 flavanones Chemical class 0.000 claims description 9
- 235000011981 flavanones Nutrition 0.000 claims description 9
- 150000002515 isoflavone derivatives Chemical class 0.000 claims description 9
- 239000004006 olive oil Substances 0.000 claims description 9
- 235000008390 olive oil Nutrition 0.000 claims description 9
- 239000002540 palm oil Substances 0.000 claims description 9
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 claims description 8
- 235000014443 Pyrus communis Nutrition 0.000 claims description 8
- 150000001720 carbohydrates Chemical class 0.000 claims description 8
- 235000005471 carotenols Nutrition 0.000 claims description 8
- 150000001748 carotenols Chemical class 0.000 claims description 8
- 235000005513 chalcones Nutrition 0.000 claims description 8
- 150000001789 chalcones Chemical class 0.000 claims description 8
- 230000002596 correlated effect Effects 0.000 claims description 8
- 235000011869 dried fruits Nutrition 0.000 claims description 8
- DEDGUGJNLNLJSR-UHFFFAOYSA-N enol-phenylpyruvic acid Chemical class OC(=O)C(O)=CC1=CC=CC=C1 DEDGUGJNLNLJSR-UHFFFAOYSA-N 0.000 claims description 8
- 229930003658 monoterpene Natural products 0.000 claims description 8
- 150000002773 monoterpene derivatives Chemical class 0.000 claims description 8
- 235000002577 monoterpenes Nutrition 0.000 claims description 8
- 235000009048 phenolic acids Nutrition 0.000 claims description 8
- 150000007965 phenolic acids Chemical class 0.000 claims description 8
- 229940068065 phytosterols Drugs 0.000 claims description 8
- 150000003248 quinolines Chemical class 0.000 claims description 8
- 150000001629 stilbenes Chemical class 0.000 claims description 8
- 235000021286 stilbenes Nutrition 0.000 claims description 8
- 235000021384 green leafy vegetables Nutrition 0.000 claims description 7
- 229940112042 peripherally acting choline derivative muscle relaxants Drugs 0.000 claims description 7
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 7
- 230000032683 aging Effects 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 150000002898 organic sulfur compounds Chemical class 0.000 claims description 6
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 5
- 239000013543 active substance Substances 0.000 claims description 5
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 235000006708 antioxidants Nutrition 0.000 claims description 5
- 230000003412 degenerative effect Effects 0.000 claims description 5
- 235000015872 dietary supplement Nutrition 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 239000005556 hormone Substances 0.000 claims description 5
- 229940088597 hormone Drugs 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 239000000654 additive Substances 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 4
- 230000000844 anti-bacterial effect Effects 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 239000000490 cosmetic additive Substances 0.000 claims description 4
- 230000006866 deterioration Effects 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- 239000003925 fat Substances 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 230000036559 skin health Effects 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 206010027654 Allergic conditions Diseases 0.000 claims description 3
- 208000024827 Alzheimer disease Diseases 0.000 claims description 3
- 208000023275 Autoimmune disease Diseases 0.000 claims description 3
- 208000020084 Bone disease Diseases 0.000 claims description 3
- 208000012659 Joint disease Diseases 0.000 claims description 3
- 208000001132 Osteoporosis Diseases 0.000 claims description 3
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 3
- 206010003246 arthritis Diseases 0.000 claims description 3
- 208000006673 asthma Diseases 0.000 claims description 3
- 239000011230 binding agent Substances 0.000 claims description 3
- 210000000988 bone and bone Anatomy 0.000 claims description 3
- 230000001276 controlling effect Effects 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- 239000003205 fragrance Substances 0.000 claims description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 3
- 208000027771 Obstructive airways disease Diseases 0.000 claims description 2
- 229940088710 antibiotic agent Drugs 0.000 claims description 2
- 239000007844 bleaching agent Substances 0.000 claims description 2
- 239000000872 buffer Substances 0.000 claims description 2
- 239000004067 bulking agent Substances 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims description 2
- 239000007854 depigmenting agent Substances 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 239000003349 gelling agent Substances 0.000 claims description 2
- 230000000887 hydrating effect Effects 0.000 claims description 2
- 239000000314 lubricant Substances 0.000 claims description 2
- 239000004014 plasticizer Substances 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 240000001987 Pyrus communis Species 0.000 claims 3
- 229930003935 flavonoid Natural products 0.000 description 31
- 235000017173 flavonoids Nutrition 0.000 description 31
- 150000002215 flavonoids Chemical class 0.000 description 26
- 150000001747 carotenoids Chemical class 0.000 description 25
- 210000003491 skin Anatomy 0.000 description 16
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 14
- 235000011987 flavanols Nutrition 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 150000002206 flavan-3-ols Chemical class 0.000 description 12
- 235000013399 edible fruits Nutrition 0.000 description 11
- 240000008415 Lactuca sativa Species 0.000 description 10
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 10
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 8
- 150000007946 flavonol Chemical class 0.000 description 8
- 235000012045 salad Nutrition 0.000 description 8
- 235000013616 tea Nutrition 0.000 description 8
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 8
- 235000010469 Glycine max Nutrition 0.000 description 7
- 244000269722 Thea sinensis Species 0.000 description 7
- 235000013365 dairy product Nutrition 0.000 description 7
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 241000220324 Pyrus Species 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 238000006722 reduction reaction Methods 0.000 description 6
- 235000014347 soups Nutrition 0.000 description 6
- 230000000699 topical effect Effects 0.000 description 6
- 230000036541 health Effects 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 4
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 4
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 4
- 239000005864 Sulphur Substances 0.000 description 4
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000003217 anti-cancerogenic effect Effects 0.000 description 4
- 230000002790 anti-mutagenic effect Effects 0.000 description 4
- 229960003237 betaine Drugs 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 235000005473 carotenes Nutrition 0.000 description 4
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 4
- 230000003292 diminished effect Effects 0.000 description 4
- 150000002212 flavone derivatives Chemical class 0.000 description 4
- 230000007407 health benefit Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 4
- 229940116852 myricetin Drugs 0.000 description 4
- 235000007743 myricetin Nutrition 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 235000005875 quercetin Nutrition 0.000 description 4
- 229960001285 quercetin Drugs 0.000 description 4
- 150000003505 terpenes Chemical class 0.000 description 4
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 4
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 3
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 3
- 235000002767 Daucus carota Nutrition 0.000 description 3
- 244000000626 Daucus carota Species 0.000 description 3
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 3
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 240000003768 Solanum lycopersicum Species 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 235000010208 anthocyanin Nutrition 0.000 description 3
- 239000004410 anthocyanin Substances 0.000 description 3
- 229930002877 anthocyanin Natural products 0.000 description 3
- 150000004636 anthocyanins Chemical class 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 3
- 150000001765 catechin Chemical class 0.000 description 3
- 235000005487 catechin Nutrition 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 229920002770 condensed tannin Polymers 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- YTAQZPGBTPDBPW-UHFFFAOYSA-N flavonoid group Chemical group O1C(C(C(=O)C2=CC=CC=C12)=O)C1=CC=CC=C1 YTAQZPGBTPDBPW-UHFFFAOYSA-N 0.000 description 3
- 239000005417 food ingredient Substances 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 235000008777 kaempferol Nutrition 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000001656 lutein Substances 0.000 description 3
- 235000012680 lutein Nutrition 0.000 description 3
- 229960005375 lutein Drugs 0.000 description 3
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 3
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 3
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 3
- 235000009498 luteolin Nutrition 0.000 description 3
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 3
- 235000012661 lycopene Nutrition 0.000 description 3
- 239000001751 lycopene Substances 0.000 description 3
- 229960004999 lycopene Drugs 0.000 description 3
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 3
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 230000037380 skin damage Effects 0.000 description 3
- 235000011888 snacks Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 3
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241001133760 Acoelorraphe Species 0.000 description 2
- 235000001270 Allium sibiricum Nutrition 0.000 description 2
- 240000007087 Apium graveolens Species 0.000 description 2
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 2
- 235000010591 Appio Nutrition 0.000 description 2
- 241000219198 Brassica Species 0.000 description 2
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- OEIJRRGCTVHYTH-UHFFFAOYSA-N Favan-3-ol Chemical compound OC1CC2=CC=CC=C2OC1C1=CC=CC=C1 OEIJRRGCTVHYTH-UHFFFAOYSA-N 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- 239000001828 Gelatine Substances 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- 235000003228 Lactuca sativa Nutrition 0.000 description 2
- 244000081841 Malus domestica Species 0.000 description 2
- ZFAHNWWNDFHPOH-YFKPBYRVSA-N S-allylcysteine Chemical compound OC(=O)[C@@H](N)CSCC=C ZFAHNWWNDFHPOH-YFKPBYRVSA-N 0.000 description 2
- IDIDJDIHTAOVLG-VKHMYHEASA-N S-methylcysteine Chemical compound CSC[C@H](N)C(O)=O IDIDJDIHTAOVLG-VKHMYHEASA-N 0.000 description 2
- 206010040954 Skin wrinkling Diseases 0.000 description 2
- 235000009337 Spinacia oleracea Nutrition 0.000 description 2
- 244000300264 Spinacia oleracea Species 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 2
- 235000008714 apigenin Nutrition 0.000 description 2
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 2
- 229940117893 apigenin Drugs 0.000 description 2
- 235000021016 apples Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000007894 caplet Substances 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- ZZIALNLLNHEQPJ-UHFFFAOYSA-N coumestrol Chemical compound C1=C(O)C=CC2=C1OC(=O)C1=C2OC2=CC(O)=CC=C12 ZZIALNLLNHEQPJ-UHFFFAOYSA-N 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 2
- 235000007240 daidzein Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 2
- 229940030275 epigallocatechin gallate Drugs 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000012055 fruits and vegetables Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000006539 genistein Nutrition 0.000 description 2
- 229940045109 genistein Drugs 0.000 description 2
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 2
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000008821 health effect Effects 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 235000001510 limonene Nutrition 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- KZMACGJDUUWFCH-UHFFFAOYSA-O malvidin Chemical compound COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 KZMACGJDUUWFCH-UHFFFAOYSA-O 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 229940052490 naringin Drugs 0.000 description 2
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 2
- 229930019673 naringin Natural products 0.000 description 2
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- VGEREEWJJVICBM-UHFFFAOYSA-N phloretin Chemical compound C1=CC(O)=CC=C1CCC(=O)C1=C(O)C=C(O)C=C1O VGEREEWJJVICBM-UHFFFAOYSA-N 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 2
- 229940032091 stigmasterol Drugs 0.000 description 2
- 235000016831 stigmasterol Nutrition 0.000 description 2
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 239000002966 varnish Substances 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 235000014101 wine Nutrition 0.000 description 2
- 229930013915 (+)-catechin Natural products 0.000 description 1
- 235000007219 (+)-catechin Nutrition 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- 235000007355 (-)-epicatechin Nutrition 0.000 description 1
- 229930013783 (-)-epicatechin Natural products 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- ZWTDXYUDJYDHJR-UHFFFAOYSA-N (E)-1-(2,4-dihydroxyphenyl)-3-(2,4-dihydroxyphenyl)-2-propen-1-one Natural products OC1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O ZWTDXYUDJYDHJR-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- PHZOWSSBXJXFOR-UHFFFAOYSA-N 2-Propenyl glucosinolate Natural products OCC1OC(SC(CC=C)=NOS(O)(=O)=O)C(O)C(O)C1O PHZOWSSBXJXFOR-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- 229940093681 4-coumaric acid Drugs 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 231100000716 Acceptable daily intake Toxicity 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 241001280436 Allium schoenoprasum Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 241000219122 Cucurbita Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 description 1
- 108091006149 Electron carriers Proteins 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 description 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 241000408747 Lepomis gibbosus Species 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- YQHMWTPYORBCMF-UHFFFAOYSA-N Naringenin chalcone Natural products C1=CC(O)=CC=C1C=CC(=O)C1=C(O)C=C(O)C=C1O YQHMWTPYORBCMF-UHFFFAOYSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 235000002725 Olea europaea Nutrition 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- ZFAHNWWNDFHPOH-UHFFFAOYSA-N S-Allyl-L-cystein Natural products OC(=O)C(N)CSCC=C ZFAHNWWNDFHPOH-UHFFFAOYSA-N 0.000 description 1
- IDIDJDIHTAOVLG-UHFFFAOYSA-N S-methyl-L-cysteine Natural products CSCC(N)C(O)=O IDIDJDIHTAOVLG-UHFFFAOYSA-N 0.000 description 1
- BHLMCOCHAVMHLD-REOHCLBHSA-N S-oxy-L-cysteine Chemical compound OC(=O)[C@@H](N)CS=O BHLMCOCHAVMHLD-REOHCLBHSA-N 0.000 description 1
- WWBNBPSEKLOHJU-CEOIDQJPSA-N Sinalbin Natural products S(=O)(=O)(O/N=C(\S[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)/Cc1ccc(O)cc1)O WWBNBPSEKLOHJU-CEOIDQJPSA-N 0.000 description 1
- PHZOWSSBXJXFOR-MYMDCHNCSA-N Sinigrin Natural products S(=O)(=O)(O/N=C(\S[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)/CC=C)O PHZOWSSBXJXFOR-MYMDCHNCSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- 241000482268 Zea mays subsp. mays Species 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 244000193174 agave Species 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 239000000420 anogeissus latifolia wall. gum Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000842 anti-protozoal effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 125000001895 carotenoid group Chemical group 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 235000007336 cyanidin Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- JKHRCGUTYDNCLE-UHFFFAOYSA-O delphinidin Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 JKHRCGUTYDNCLE-UHFFFAOYSA-O 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- QJKMIJNRNRLQSS-WEVVVXLNSA-N echinatin Chemical compound COC1=CC(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1 QJKMIJNRNRLQSS-WEVVVXLNSA-N 0.000 description 1
- 230000027721 electron transport chain Effects 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000019261 food antioxidant Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- 230000000273 goitrogenic effect Effects 0.000 description 1
- 235000014168 granola/muesli bars Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000019314 gum ghatti Nutrition 0.000 description 1
- 201000010235 heart cancer Diseases 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000024348 heart neoplasm Diseases 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 239000008311 hydrophilic ointment Substances 0.000 description 1
- KOTBWDXNYNTNIY-YHEDCBSUSA-N hydroxycarotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C KOTBWDXNYNTNIY-YHEDCBSUSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002766 immunoenhancing effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 150000002628 limonene derivativess Chemical class 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000011475 lollipops Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 235000009584 malvidin Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 239000008164 mustard oil Substances 0.000 description 1
- ARGKVCXINMKCAZ-UZRWAPQLSA-N neohesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UZRWAPQLSA-N 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- HKUHOPQRJKPJCJ-UHFFFAOYSA-N pelargonidin Natural products OC1=Cc2c(O)cc(O)cc2OC1c1ccc(O)cc1 HKUHOPQRJKPJCJ-UHFFFAOYSA-N 0.000 description 1
- 235000006251 pelargonidin Nutrition 0.000 description 1
- XVFMGWDSJLBXDZ-UHFFFAOYSA-O pelargonidin Chemical compound C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 XVFMGWDSJLBXDZ-UHFFFAOYSA-O 0.000 description 1
- 229930015721 peonidin Natural products 0.000 description 1
- 235000006404 peonidin Nutrition 0.000 description 1
- XFDQJKDGGOEYPI-UHFFFAOYSA-O peonidin Chemical compound C1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 XFDQJKDGGOEYPI-UHFFFAOYSA-O 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229930015717 petunidin Natural products 0.000 description 1
- 235000006384 petunidin Nutrition 0.000 description 1
- AFOLOMGWVXKIQL-UHFFFAOYSA-O petunidin Chemical compound OC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 AFOLOMGWVXKIQL-UHFFFAOYSA-O 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- QKFAFSGJTMHRRY-OCFLFPRFSA-M potassium;[(e)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylbut-3-enylideneamino] sulfate Chemical compound [K+].OC[C@H]1O[C@@H](S\C(CC=C)=N\OS([O-])(=O)=O)[C@H](O)[C@@H](O)[C@@H]1O QKFAFSGJTMHRRY-OCFLFPRFSA-M 0.000 description 1
- 235000013573 potato product Nutrition 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 235000021455 prepackaged meals Nutrition 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 235000020236 pumpkin seed Nutrition 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- WWBNBPSEKLOHJU-RFEZBLSLSA-N sinalbin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1S\C(=N/OS(O)(=O)=O)CC1=CC=C(O)C=C1 WWBNBPSEKLOHJU-RFEZBLSLSA-N 0.000 description 1
- 235000017291 sinigrin Nutrition 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000003687 soy isoflavones Nutrition 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 108010058651 thioglucosidase Proteins 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 150000003669 ubiquinones Chemical class 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
WO 2006/053379 PCT/AU2005/001741 1 IMPROVED NUTRACEUTICAL COMPOSITION Field of the invention The present invention relates to a nutraceutical and/or cosmetic composition and/or modified food composition derived from one or more extracts of various plant 5 components. The present invention also relates to a method of prophylactically or therapeutically treating a disease or degenerative effect Background of the invention Increasingly, there has been an interest in the role of specific foods composed of compounds that have the potential to favourably affect human biology. Plants and plant 10 derived foods are of particular interest, the beneficial compounds contained in them known as phytonutrients. As well as contributing to the colour, texture, flavour and smell of plants and plant derived foods, phytonutrients have complementary and overlapping biological effects, including antioxidant effects, modulation of detoxification enzymes, stimulation of the 15 immune system, modulation of hormone metabolism and antibacterial and antiviral effects. The growing array of phytonutrients opens up opportunities for healthier food choices and for the development of functional foods to serve particular physiological or pathological needs. Health benefits are increasingly used as a selling point for new food 20 products. Many plant foods are used as food ingredients because of their content of phytonutrients, apart from the conventional nutrients. However, there are numerous problems in considering the place of phytonutrients in human health, including that they are numerous, are consumed in conjunction with a few essential nutrients, and their net interactive effect ultimately requires an understanding of food itself and food intake 25 patterns. Phytonutrients can be categorised in accordance with either their plant sources, WO 2006/053379 PCT/AU2005/001741 2 chemical structure or functions. Presently, phytonutrients in food products are classified according to their functions, such as antioxidants or phytoestrogens, which reflect phytonutrient content. This classification is less than satisfactory however as the actual health benefits many phytonutrients provide is, as yet, poorly defined. For convenience, 5 discussion of phytonutrients is conducted based on a classification by chemical structure, for example carotenoids, flavonoids and glucosinolates. However, such a classification is not admitted to be commonly used or employed, particularly in the food industry. Flavonoids are polyphenolic compounds comprising 15 carbon atoms, with two aromatic 10 rings connected by a three carbon bridge. They are found throughout the plant kingdom, present in high concentrations in the epidermis of leaves and the skin of fruit. Flavonoids have been found in fruits and vegetables including apples, pears and onions as well as in tea and wine. In plants, flavonoids, as secondary metabolites, are involved in diverse processes, such as UV protection, pigmentation, stimulation of nitrogen-fixing 15 nodules and disease resistance. Flavonoids consist mainly of flavonols (kaempferol, quercetin, myricetin), flavones (apigenin, luteolin), flavanols (catechins, epicatechins, proanthocyanins), isoflavones (daidzein, genistein), flavanones (naringin, hesperidin), and anthocyanidins. However, the term 'flavonoid' is sometimes used in the literature to describe only flavonols. By 20 acting as antioxidants, flavonoids reduce oxidative damage to DNA and influence other processes of cell proliferation that are regulated through the oxidation-reduction reactions. In addition, they can modulate the activity of specific phase I and phase 11 enzymes and therefore inhibit the metabolic activation of carcinogens. Flavonols, in particular epigallocatechin gallate (EGCC), have been identified as the 25 principal antimutagenic and anticarcinogenic compound in green tea. The beneficial effects of drinking tea have been observed in relation to blood pressure, serum cholesterol and other lipids. Carotenoids (#-carotene, lycopene, lutein) are the most well-known of a group known as terpenoids, which are structurally very diverse and are classified according to the WO 2006/053379 PCT/AU2005/001741 3 number of C5 isoprenoid units incorporated in their structures. The pro-vitamin A activity is probably the first function known for dietary carotenoids, especially P-carotene, although not all of them possess this activity. Most carotenoids possess antioxidant, immuno-enhancement, antimutagenic, and anticarcinogenic functions. Because of the 5 antioxidant property of carotenoids, the possibility exists that these compounds reduce lipid peroxidation, oxidative stress and free radical damage. Accordingly, they may protect against coronary heart disease, cancer and cataracts. Carotenoids are responsible for many of the red, orange and yellow colours of edible fruits and vegetables, for example, carrots, tomatoes and corn. They are also found in green leafy 10 vegetables such as spinach. Nitrogen and sulphur containing compounds, such as the glucosinolates found in the members of the Brassica genus (broccoli, cabbage, mustard), have received much attention recently. They are nitrogen and sulphur containing glycosides which in damaged tissues come into contact with the myrosinase enzyme and are hydrolysed, 15 releasing the aglycone. Isothiocyanates and organosulphides are found in mustard oils and are widely distributed in plants. They have a variety of pharmacological and toxic activities, including goitrogenic, antibacterial, antifungal and antiprotozoal actions. Several substances in this group could block the toxic and neoplastic effects of a wide variety of 20 chemical carcinogens. Plants of the A//ium genus (garlic, onions, leeks, chives) are also rich in sulphur containing compounds, such as S-methyl cysteine sulphoxide and S-allyl cysteine sulphoxide. There is some evidence that onions, garlic and compounds derived from them can exhibit health-promoting effects, for example, garlic is known for its health 25 promoting effects in relation to cardiovascular disease and some forms of cancer. Compounds in the terpenoid group (other than carotenoids) that have been reported in the literature include limonenes, which have the fragrance of oranges and lemons, glycyrrhizic acid found in liquorice root, and sterols (sitosterol and stigmasterol) commercially produced from soy beans. Coenzyme Q or ubiquinones, which are found WO 2006/053379 PCT/AU2005/001741 4 in all organisms and function as electron carriers for the electron transport chain in mitochondria, are also terpenoids with C40-C50 side chains. The health-promoting effects of certain phytonutrients can be exemplified in relation to skin ageing. It has recently been found that certain foods are associated with less skin 5 wrinkling (Purba et al., J. Am. Col. Nutr., 2001, 20, 71-80). Previously, it was widely assumed that genetic predisposition, age, actinic damage and cigarette smoking accounted for most of the skin ageing suffered by much of the population. Purba et aL. found foods such as apple, pear, tea, onion, leek, dried fruits and green leafy vegetables were associated with less skin wrinkling. Table 1 shows the amount (in 10 g/day) of the foods and the associated phytonutrients required to effect a one unit reduction in skin damage. Table I The amount of foods and the associated phytonutrients required to effect a one unit reduction in skin damage Food Amount Phytonutrient Amount Apple/pear 50.3 g/day Flavonols 1-40 mg/day Tea 2000 g/day Carotenoids 15-1000 pg/day Onion/leek 27.2 g/day Anthocyanins 3-8 mg/day Dried fruits 20.8 g/day Catechins 10-200 mg/day Green leafy 19.1 g/day vegetables 15 Further evidence for food antioxidants being protective against skin damage and cancer risk comes from animal studies with tea catechins (flavonoids) and palm fruit water extract (polyphenols). However, little is known of the mechanism(s) or key elements in such products.
WO 2006/053379 PCT/AU2005/001741 5 Food-derived flavonoids such as quercetin, kaempferol and myricetin have been shown to have antimutagenic and anticarcinogenic effects in vitro and in vivo. The first population study that drew attention to the health benefits of dietary flavonoids is the Zutphen Elderly Study (Hertog et al. Lancet 1993; 142: 1007-11; Keli et al, Arch Intern 5 Med 1996; 156: 637-42), which was an extension of the Dutch contribution to the Seven Countries Study (Hertog et al. Arch Intern Med 1995;155;381-6). The measurements of five major food flavonoids (the flavanols quercetin, kaempferol and myricetin, and the flavones apigen and luteolin) in 28 vegetables, 9 fruits, and beverages mostly commonly consumed in the Netherlands enabled the estimation of flavonoid intake of 10 the study population. These data have been used in a number of prospective cohort studies and cross-cultural studies on the relation between flavonoid intake and cancer and cardiovascular disease. Even though flavonoids have been shown in vitro and in vivo to possess antimutagenic and anticarcinogenic properties, dietary flavonoid intake was not an important 15 determinant of cancer mortality. No associations were found between flavonol and flavone intake and total and site-specific cancer mortality in the Zutphen Elderly Study. Similar results were also observed in the Seven Countries Study, where the intake of flavanols and flavones ranged from 3 mg/day in a Finnish cohort to 70 mg/day in a Japanese cohort. 20 In the Netherlands Cohort study of 120,850 men and women aged 55-69 years, the intake of flavonols and flavones was not associated with the risk of cancer of the colon or the stomach or the lung during 4.3 years of follow-up. However, in a prospective cohort study of about 10,000 men and women aged 15-99 years in Finland, a reduction in risk of lung cancer of about 50% was found in the highest quartile of flavonol intake 25 after 24 years of follow-up. No reduction in risk of cancer at other sites was found. It is difficult, however, to determine the required intakes of the various phytonutrients found in plants and plant derived foods that will lead to improved health outcomes. It would be a significant advance in the art if determinants favourable to the prophylactic or therapeutic treatment of a disease or degenerative effect could be located.
WO 2006/053379 PCT/AU2005/001741 6 Accordingly, it is an object of the present invention to overcome, or at least alleviate, one or more of the problems or deficiencies in the prior art. Summary of the invention In a first aspect of the present invention there is provided a nutraceutical composition 5 including one or more extracts of one or more plant components, the one or more extracts providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value predetermined to provide a therapeutically or prophylactically desirable effect. Inventors have surprisingly found that administration of the nutraceutical composition 10 according to this aspect of the present invention, orally or topically, may function to treat a disease or a degenerative effect. For example, it has been found that administration of the nutraceutical composition according to this aspect of the present invention, orally or topically, may improve skin health, reduce signs of skin ageing and/or reduce other forms of skin deterioration. For example, long-term supplementation for 12 weeks with 15 24 mg/d of a carotenoid mix supplying similar amounts of beta-carotene, lutein and lycopene ameliorates redness of human skin induced by UV light. In addition, the nutraceutical composition may optionally include a nutraceutically acceptable carrier. The term "nutraceutical" (or nutraceutical), as used herein, refers to any food or food 20 ingredient (or additive) considered to provide medical or health benefits, including the prevention or treatment of disease. Food and food substances may qualify for health claims only if they meet FDA requirements, which require that the claims be supported by sufficient scientific evidence. However, nutraceuticals are not regulated as strictly as drugs. 25 The term "extract" as used herein refers to any subset of a plant or plant product and may include, but is not limited to juice, pulp, infusion, cutting, distillate, distillation residue, pressing, nectar, pomace (crushing residue), etc.
WO 2006/053379 PCT/AU2005/001741 7 The term "plant component" may include, but is not limited to, any one or more of the following: leaf, stem, root, fruit, seed, nut, tuber, bulb, flower or branch, and the like, whether used in a fresh form or a dried form. A plant may be selected from the group consisting of, but not limited to one or more of 5 olive trees, palm trees, fruit trees, plants used to make tea, other plants from which fruit and vegetables are derived, etc. The "minimum value" is indicated by way of a numeric "score" which gives an indication of the phytonutrient nutritional quality of the nutraceutical composition (or other composition depending on the aspect of the invention). 10 The minimum value is predetermined based on, for example, the Reference Intakes (RI) of the various phytonutrients present in the composition. The RI is a nutrient-based reference value for use in, inter alia, planning and assessing diets. The nutrient-based values are based on the lowest continuing intake level of a nutrient that, for a specified indicator of adequacy, will maintain a defined level of nutriture in an individual. The RI is 15 the amount of a phytonutrient per 100 kcal that a person should consume to ensure adequate intake of the phytonutrient for health purposes. A score may be calculated using any suitable scoring system. The following is a description of one suitable scoring system. However, modifications to this system may be implemented to improve the described system or simply generate a new system. 20 The scoring system being described has five components of varying significance which are based on the content, variety and intactness of the phytonutrients in a nutraceutical composition. The described scoring system has an overall range of 0 to 100. Components 1 to 3 of the described scoring system are each scored in the range of 0 to 25 and the score given is based on the amount of the three major groups of 25 phytonutrients present in a composition - (1) flavonoids, (2) carotenoids and (3) miscellaneous (other phytonutrients, including nitrogen or sulphur containing compounds). For the purposes of this scoring system the phytonutrients have been classified on the basis of their structures. Table 2 lists the phytonutrient groups WO 2006/053379 PCT/AU2005/001741 8 (numbered in accordance with their component number) and the sub-groups and individual compounds making up the sub-groups, as well as the major sources of these phytonutrients. Table 2 5 Component I - Phytonutrient groups and sub-groups Group Sub-group Individual compound Major food source or phytonutrient 1. Flavonoids 1.1 Flavonols Kaemferol Apples, onions, Quercetin tomatoes, lettuce, Myricetin celery, tea, red 1.2 Flavones Apigenin wines Luteolin 1.3 Flavanols (+)-Catechin Tea (-)-Epicatechin (-)-Epigallocatechin (-)-Epicatechin gallate Proanthocyanidins 1.4 Anthocyanidins Pelargonidin Cherries, Cyanidin blueberries Delphinidin Peonidin Petunidin Malvidin 1.5 Flavanones Hesperdin Citrus fruits Neohesperidin Naringin 1.6 Chalcones & Retrochalcone dichalcones Isosalipurpuring Phloretin 1.7 Isoflavones Genistein Pulses, eg, soy Daidzein Coumestrol 2. Carotenoids 2.1 Provitamin A p-carotene Red to orange hydrocarbon a-carotene pigmented fruits carotenoids and vegetables, WO 2006/053379 PCT/AU2005/001741 9 Group Sub-group Individual compound Major food source or phytonutrient 2.2 Non-provitamin A Lycopene green leafy hydrocarbon vegetables, eg, carotenoids carrots, tomatoes 2.3 Hydroxy carotenoids Lutein and spinach Zeaxanthin Cryptoxanthin 3. Miscellaneous 3.1 Glucosinolates Sinalbin Cruciferous Sinigrin vegetables, eg, broccoli, cauliflower 3.2 Allium Cysteine sulphoxide Garlic, onions, organosulphur derivatives chives, leeks compounds 3.3 Phytosterols p-sitosterol Pumpkin seeds Campesterol Stigmasterol Avenosterol 3.4 Monoterpenes Limonene Citrus fruits, Thymol caraway seeds 3.5 Hydroxy-cinnamates Caffeic acid Ferulic acid Cinapic acid 4-coumaric acid 3.6 Phenolic acids Tannins Salicylates 3.7 Stilbenes Resveratrol 3.8 Choline derivative Betaine Component 4 is scored in the range of 0 to 15 and is based on the amount of variety of phytonutrients in a nutraceutical composition. Component 5 is scored in the range of 0 to 10 and is a measure of the degree to which fresh plant components are altered, 5 either physically, chemically or both from their natural state for incorporation into the extract and/or the nutraceutical composition.
WO 2006/053379 PCT/AU2005/001741 10 The described scoring system is summarised in Table 3. Table 3 Components of a phytonutrient scoring system Component Description Range Criteria for Criteria for of score maximum score minimum score Phytonutrient group 1 Flavonoids 0 to 25 100% of Reference 0% of Reference 2 Carotenoids 0 to 25 Intakes for each group Intakes for each group 3 Miscellaneous 0 to 25 4 Phytonutrient variety a. Flavonoids 0 to 7 Number of Phytonutrients with b. Carotenoids 0 to 3 phytonutrient sub- insignificant trace c. Miscellaneous 0 to 5 groups reaches or amounts exceeds the threshold number 5 Phytonutrient 0 to 10 Not undergoing any Undergoing vigorous intactness food processes other food processes than basic cooking (100% phytonutrients in natural original form) a Component scores between the maximum and minimum cut-off points are assigned 5 proportionately. The score for components 1 to 3 (hereafter simply referred to as the phytonutrient groups) for any given nutraceutical composition is determined by the phytonutrient content of the composition expressed as the phytonutrient density (amount of phytonutrient in pig (or mg) per 1000 kJ energy (or per 100 kcal) derived from that 10 particular composition). Each phytonutrient group is scored by comparing the phytonutrient density of the composition to the Reference Intakes (RI) for that phytonutrient. A score is assigned by first calculating the phytonutrient density percentage of the RI for each phytonutrient in the group. Second, a score from 0 to 25 is proportionately assigned based upon the WO 2006/053379 PCT/AU2005/001741 11 percentage of the RI of phytonutrients in each group, with 25 being the highest score for each phytonutrient group when one serving size of the nutraceutical composition provides 100% of the RI of the phytonutrients of that group. Determining adequate intakes of specific food intakes and related phytonutrients is not 5 straightforward. The RI of a phytonutrient may be based on reports from various cohort studies, where a large number of participants are followed up for long periods of time in order to observe disease incidence. Evidence may be gathered from research in which the associations of phytonutrient intake or consumption of phytonutrient rich foods and disease outcome are examined. The disease outcome may include risk of all-cause 10 mortality, risk of cancer, heart disease and other diseases, and association with risk factors for disease. The RI may also be determined from daily phytonutrient intakes of populations or sub populations with longevity or with reduced risk of chronic diseases. For example, the Zutphen Elderly Study (Keli et al., Arch Intern Med 1996; 156: 637-42; Hertog et al., 15 Lancet 1997; 349: 699) shows that middle-aged men with flavonoid (flavonol + flavone) intake > 18.3 mg/d had a 50% reduction in the risk of stroke, and those with flavonol intake > 19.1 mg/d had a 42% reduction in the risk of coronary heart disease mortality. In this case, the daily reference intake for the flavonol sub-group would be set as 20 mg/day. In this example, the RI for the flavonol sub-group would be 1 mg/100 kcal 20 based on a 2000 kcal per day diet. In an alternate scoring system, the RI may be assigned to the phytonutrient group. In such a system, the RI for the phytonutrient group may be derived from the RI for the major sub-group of the phytonutrient group or from the total RI for all sub-groups. In relation to component 4 (assessment of phytonutrient variety), the scoring system 25 counts the number of phytonutrient sub-groups that contribute substantially to meeting the three phytonutrient group requirements. A substantial contribution could be, for example, when the percentage of RI for each phytonutrient of the sub-group is summed, a total percentage of greater than 5% for the phytonutrient sub-group. Phytonutrient groups and subgroups are outlined in Table 1. Phytonutrients (and their derivatives) that WO 2006/053379 PCT/AU2005/001741 12 fall in the same sub-group are counted only once. For each of the phytonutrient groups, a threshold number is set and a maximum score is given even though the number of different phytonutrients exceeds the threshold number. In the described scoring system the threshold numbers for flavonoids is 7, for carotenoids is 3 and for the miscellaneous 5 group, the threshold number is 5. Therefore, the variety score has a range from 0 to 15. Component 5 (the assessment of the intactness of phytonutrients) of the scoring system counts the number of food processing procedures that a nutraceutical composition undergoes (Table 4). The more food processing the composition undergoes, the more the integrity of the phytonutrients is diminished. Thus, the higher number of food 10 processes undergone by the food item, the lower the score will be for component 5. Table 4 Processes during food manufacturing which could diminish the integrity of phytonutrients Type of food processing Procedure Physical Pulverisation Chemical Fractionation (crystallisation / precipitation) Solvent extraction Use of chemicals or enzymes that interact with phytonutrients Physico-chemical Dehydration e.g. high temperature drying 15 The therapeutically or prophylactically desirable effect may relate to any disease or condition known to the person skilled in the art. For example, such diseases or conditions may include, but are not limited to, skin ageing, skin health, skin deterioration, skin conditions, cancer, cardiovascular disease, Alzheimer's disease, bone and joint diseases including osteoporosis and arthritis, obstructive airways WO 2006/053379 PCT/AU2005/001741 13 diseases including asthma, allergic conditions, conditions affecting the gastrointestinal tract, autoimmune diseases, and diabetes. A person skilled in the art would understand that the scoring system described above may also be applied to plant or plant components and even to animal-derived food 5 products that may contain phytonutrients acquired when plant food is consumed by the animal. Preferably, the nutraceutical composition includes an effective amount of phytonutrient materials selected from the group consisting of flavonols, flavones, flavanols, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A 10 hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates, allium organosulphur compounds, phytosterols, monoterpenes, hydroxycinnamates, phenolic acids, stilbenes, choline derivatives, or a combination thereof. The minimum value will generally be determined depending on the type of nutraceutical 15 composition being considered. For example, a nutraceutical composition of an embodiment of the present invention may include a combination of phytonutrient materials such that the minimum value is about 25. Preferably, the value may be about 40, more preferably about 60. The nutraceutical composition according to this aspect of the present invention may 20 further include one or more secondary nutraceutical components active nutritionally and/or therapeutically. The secondary nutraceutical component may be selected from one or more of vitamins, minerals, saccharides and/or other carbohydrates, fats, other nutritional supplements, hormones, and pharmaceuticals. The secondary nutraceutical component, when present, may comprise from 25 approximately 0.05% to 50% by weight, preferably approximately 1 % to 40% by weight, more preferably 5% to 25% by weight, based on the total weight of the pharmaceutical composition.
WO 2006/053379 PCT/AU2005/001741 14 The nutraceutical composition according to this aspect of the present invention may further include a pharmaceutically acceptable carrier or excipient. The nutraceutical composition may be formulated for administration utilising a suitable route. The nutraceutical composition may be formulated for oral, topical, intravenous, 5 intramuscular, intrarectal, transdermal, sublingual, subcutaneous or intranasal administration. An oral or topical route is preferred. When an oral route is chosen, the nutraceutical composition may be formulated as a food ingredient, food additive, tablet, capsule including soft gelatine capsules, caplet, lozenge, liquid including syrup, oil and suspension, powder, granules, chewing gum or 10 the like. When a topical route is chosen, the nutraceutical composition may be formulated as a liquid, oil, paste, solution, dispersion, emulsion, lotion, gel, varnish or cream. In a preferred embodiment, the nutraceutical composition according to this aspect of the present invention may include a source of monounsaturated fatty acids or a derivative 15 thereof. Preferably, the source of the monounsaturated fatty acid is an edible oil. More preferably the edible oil is olive oil or red palm oil, or an extract thereof, or a mixture thereof. Preferably, the source of monounsaturated fatty acids is present in an amount of from approximately 1 mg to 25 g, preferably 50 mg to 10 g, more preferably 100 mg to 5 g. In 20 a further preferred embodiment of the present invention, the amount of monounsaturated fatty acids present in the nutraceutical composition amounts to a preferred daily intake of the monounsaturated fatty acids. In another preferred embodiment of this aspect of the present invention, the nutraceutical composition includes an extract from one or more of leafy green 25 vegetables, garlic, onion, leeks, apple, pear, dried fruits or other food sources of the required phytonutrients, or a mixture thereof, with a source of monounsaturated fatty acids. Preferably, the source of the monounsaturated fatty acid is an edible oil. Most WO 2006/053379 PCT/AU2005/001741 15 preferably, the edible oil is olive oil or red palm oil, an extract thereof, or a mixture thereof. In addition, the nutraceutical composition may optionally include a nutraceutically acceptable carrier. 5 Preferably, the extracts of the plant components are present in an amount of approximately 1 % to 99% by weight, preferably approximately 5% to 75% by weight, preferably approximately 10 to 50% by weight, based on the total weight of the composition. In a further aspect of the present invention, there is provided a cosmetic composition 10 including one or more extracts of one or more plant components, the extracts providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value predetermined to provide a therapeutically or prophylactically desirable effect. Preferably, the cosmetic composition includes an effective amount of phytonutrient 15 materials selected from the group consisting of flavonols, flavones, flavanols, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates, allium organosulphur compounds, phytosterols, monoterpenes, hydroxycinnamates, phenolic acids, stilbenes, choline derivatives, or a combination 20 thereof. The minimum value will generally be determined depending on the type of nutraceutical composition being considered. For example, the cosmetic composition according to a preferred aspect of the present invention may include a combination of phytonutrient materials such that the minimum value is about 25. Preferably, the value may be about 25 40, more preferably about 60. In a preferred embodiment, the cosmetic composition according to this aspect of the present invention may include a source of monounsaturated fatty acids or a derivative WO 2006/053379 PCT/AU2005/001741 16 thereof. Preferably, the source of the monounsaturated fatty acid is an edible oil. Most preferably the edible oil is olive oil or red palm oil, or an extract thereof, or a mixture thereof. Preferably, the source of monounsaturated fatty acids is present in an amount of from 5 approximately I mg to 25 g, preferably 50 mg to 10 g, more preferably 100 mg to 5 g. In a further preferred embodiment of the present invention, the amount of monounsaturated fatty acids present in the cosmetic composition amounts to a preferred daily intake of the monounsaturated fatty acids. In another preferred embodiment of this aspect of the present invention, there is 10 provided a cosmetic composition including an extract from one or more of leafy green vegetables, garlic, onion, leeks, apple, pear, dried fruits or other food sources of the required phytonutrients, or a mixture thereof, with a source of monounsaturated fatty acids. Preferably, the source of the monounsaturated fatty acid is an edible oil. Most preferably, the edible oil is olive oil or red palm oil, an extract thereof, or a mixture 15 thereof. The cosmetic composition of this aspect of the invention may further include a pharmaceutically acceptable carrier or excipient. Preferably, the extracts of the plant components are present in an amount of approximately 1 to 99% by weight, preferably approximately 5% to 75% by weight, 20 preferably approximately 10 to 50% by weight, based on the total weight of the composition. The cosmetic composition may be formulated for administration utilising a suitable route. The cosmetic composition may be formulated for oral, topical, intravenous, intramuscular, intrarectal, transdermal, subcutaneous, sublingual or intranasal 25 administration. An oral or topical route is preferred. When an oral route is chosen, the nutraceutical composition may be formulated as a food ingredient, food additive, tablet, capsule including soft gelatine capsules, caplet, WO 2006/053379 PCT/AU2005/001741 17 lozenge, liquid including syrup and oil, suspension, powder, granules, chewing gum or the like. When a topical route is chosen, the nutraceutical composition may be formulated as a liquid, oil, paste, solution, dispersion, emulsion, lotion, gel, varnish or cream. 5 The cosmetic composition may also further include one or more cosmetic additives. The cosmetic additives may be selected from the group consisting of water-soluble or liposoluble dyes, fillers, lipophilic or hydrophilic active agents, fragrances, additional carriers or excipients, lubricants, buffers, antibacterials, bulking agents, plasticisers, binding agents, antioxidants and stabilising agents. 10 Suitable fillers or excipients may be selected from the group consisting of talc, titanium dioxide, starch, cornstarch, modified cornstarch, kaolin, cellulose (microcrystalline or powdered) and mixtures thereof. Suitable binding agents include polyvinyl pyrrolidine, hydroxypropyl cellulose and hydroxypropyl methyl cellulose. 15 Suitable solution vehicles include, but are not limited to, ethanol, water, propylene glycol, butylene glycol, acetone, or pharmaceutically acceptable vehicles. In a further preferred embodiment, the cosmetic composition may further include an active agent selected from the group consisting of hydrating agents, UV screening agents, depigmenting agents, bleaching agents and tensioning agents. 20 Suitable lotion bases include, but are not limited to, hydrophilic ointment or petrolatum. Suitable gelling agents include, but are not limited to, xanthan gum, gellan gum, carboxymethylcellulose, polyquaternium-10, methyl cellulose, ethyl cellulose, hydroxyethylcellulose, hyd roxypropylcellu lose, chitosan, hyd roxyp ropylmethylcellulose, agar-agar, carrageenans, alginates, carob gum, guar gum, gum Arabic, karaya gum, 25 gum tragacanth, ghatti gum, pectins, gelatin, caseinates, hydroxypropyl guar, ammoniated glycyrrhizinate and carbomer.
WO 2006/053379 PCT/AU2005/001741 18 In another aspect of the invention there is provided a modified food composition including a nutraceutical composition, as discussed above. The modified food composition may be characterised by exhibiting a numerical value of phytonutrient quality above a predetermined reference value. The predetermined reference value may 5 equate to a maximum numerical value for an unmodified food composition. The modified food composition may include any of the following: * flour based products, including bread, cakes, pastries, pasta etc * dairy products, including milk, ice-cream, yoghurt, cheese etc * cereal 10 0 grain based products, including rice based products such as rice cakes, corn based products such as pop corn etc * confections, including lollies, chocolates and the like e non-dairy based products, such as soy based products * products derived at least in part from fruit, including tarts, pies, muesli bars, 15 juices, cordials, tinned fruit, snack foods * products derived at least in part from vegetables, including soups, juices, snack foods including potato products such as chips, stocks e nut based products, including snack foods such as nut bars e pre-packaged meals, including frozen meals 20 Preferably, the food composition includes an effective amount of phytonutrient materials selected from the group consisting of flavonols, flavones, flavanols, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, WO 2006/053379 PCT/AU2005/001741 19 non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates, allium organosulphur compounds, phytosterols, monoterpenes, hydroxycinnamates, phenolic acids, stilbenes, choline derivatives, or a combination thereof. The minimum value will generally be determined depending on the type of nutraceutical 5 composition being considered. For example, the food composition according to a preferred aspect of the present invention may include a combination of phytonutrient materials such that the minimum value is about 25. Preferably, the value may be about 40, more preferably about 60. The food composition according to this aspect of the present invention may further 10 include one or more secondary nutraceutical components active nutritionally and/or therapeutically. The secondary nutraceutical component may be selected from one or more of vitamins, minerals, saccharides and/or other carbohydrates, fats, other nutritional supplements, hormones, and pharmaceuticals. The secondary nutraceutical component, when present, may comprise from 15 approximately 0.05% to 50% by weight, preferably approximately 1% to 40% by weight, more preferably 5% to 25% by weight, based on the total weight of the pharmaceutical composition. In a preferred embodiment, the composition according to this aspect of the present invention may include a source of monounsaturated fatty acids or a derivative thereof. 20 Preferably, the source of monounsaturated fatty acids is present in an amount of from approximately 1 mg to 25 g, preferably 50 mg to 10 g, more preferably 100 mg to 5 g. In a further preferred embodiment of the present invention, the amount of monounsaturated fatty acids present in the food composition amounts to a preferred daily intake of the monounsaturated fatty acids. Preferably, the source of 25 monounsaturated fatty acid is an edible oil. More preferably, the edible oil is olive oil, red palm oil or an extract thereof, or a mixture thereof. In another preferred embodiment of this aspect of the present invention, the WO 2006/053379 PCT/AU2005/001741 20 composition includes an extract from one or more of leafy green vegetables, garlic, onion, leeks, apple, pear, dried fruits or other food sources of the required phytonutrients, or a mixture thereof, with a source of monounsaturated fatty acids. Preferably, the extracts of the plant components are present in an amount of 5 approximately 1 to 99% by weight, preferably approximately 5% to 75% by weight, more preferably approximately 10 to 50% by weight, based on the total weight of the composition. Preferably, the composition is used to prophylactically or therapeutically treat skin ageing, skin health, skin deterioration, skin conditions, cancer, cardiovascular disease, 10 Alzheimer's disease, bone and joint diseases including osteoporosis and arthritis, obstructive airways diseases including asthma, allergic conditions, conditions affecting the gastrointestinal tract, autoimmune diseases, and diabetes.. Preferably, the composition is selected from the group consisting of a nutraceutical composition and a cosmetic composition as described above. 15 In yet another aspect of the invention there is provided a method of prophylactically or therapeutically treating a disease or degenerative effect which method includes administering to a human a composition including one or more extracts of one or more plant components, the extracts providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value predetermined to provide a 20 therapeutically or prophylactically desirable effect. In another aspect of the present invention there is provided a method of determining the nutritional value of a nutraceutical composition and applying a phytonutrient nutritional score thereto which method includes: (a) determining a nutritional characteristic(s) of the nutraceutical 25 composition, the nutritional characteristics including phytonutrient content, phytonutrient variety and phytonutrient integrity of the food substance; WO 2006/053379 PCT/AU2005/001741 21 (b) correlating the nutritional characteristic(s) with a predetermined value range(s); and (c) summing the correlated nutritional characteristics to derive a phytonutrient nutritional score indicative of the nutritional value of the 5 nutraceutical composition. In yet another aspect the present invention provides a method of determining the nutritional value of a food composition and applying a phytonutrient nutritional score thereto. Accordingly, the method includes: (a) determining a nutritional characteristic(s) of the food substance, the nutritional 10 characteristics including phytonutrient content, phytonutrient variety and phytonutrient integrity of the food substance; (b) correlating the nutritional characteristic(s) with a predetermined value range(s); and (c) summing the correlated nutritional characteristics to derive a phytonutrient 15 nutritional score indicative of the nutritional value of the food substance. The food composition may be of any suitable type as described above. The food substance may include a dietary supplement. The food substance is preferably a flour based substance, a substance containing and/or consisting of fruit and/or vegetables, a rice-based substance or a dairy-based substance. 20 The phytonutrient content, phytonutrient variety and phytonutrient integrity may be determined as described above. Preferably, the predetermined value ranges are the Reference Intakes described above. More preferably, the predetermined value ranges are determined at regular intervals based on the information available regarding optimal phytonutrient intake at the time. 25 The phytonutrient nutritional score may be determined as described above. Preferably, phytonutrient nutritional scores are given in the range of 0 to 100.
WO 2006/053379 PCT/AU2005/001741 22 Preferably, the predetermined value ranges may be compiled in order to create an index of the predetermined value ranges. Similarly, the phytonutrient nutritional scores which have been determined may be independently compiled in order to create an index of the phytonutrient nutritional 5 scores. In a further aspect the invention provides a method of controlling the nutritional value of a nutraceutical composition and/or a cosmetic composition and/or a food composition consumed by an individual. Accordingly, the method includes: (a) determining the phytonutrient nutritional score of a food substance using the 10 abovementioned method of determining the nutritional value of a food substance; and (b) modifying the nutritional value of a food substance by incorporating an additive into the food substance. Preferably, the method is used to increase the phytonutrient nutritional score of the food 15 substance. In yet another aspect the invention provides a computer useable medium for determining the nutritional value of nutraceutical composition and/or a cosmetic composition and/or a food composition. Accordingly, such medium includes: (a) means for determining nutritional components of the food substance, the 20 nutritional components including phytonutrient content, phytonutrient variety and phytonutrient integrity of the food substance; (b) means for correlating the nutritional components to predetermined value ranges; (c) means for summing the correlated nutritional components to derive a 25 phytonutrient nutritional score indicative of the nutritional value of the food WO 2006/053379 PCT/AU2005/001741 23 substance; and (d) means for displaying the phytonutrient nutritional score. The computer useable medium may be stored in any suitable manner known per se in the prior art. For example the medium may be selected from a compact disk, digital 5 video disk, hard drive or floppy disk. Preferably, the computer useable medium is arranged to provide, as an output, a phytonutrient nutritional score and/or a list of any phytonutrient nutritional scores determined by the method described above so as to form an index of phytonutrient nutritional scores. 10 The present invention will now be more fully described with reference to the accompanying example. It should be understood, however, that the description following is illustrative only and should not be taken in any way as a restriction on the generality of the invention described above. EXAMPLE I - Calculating Reference Intakes 15 The following Reference Intakes were calculated based on the data published in the cited references. Generally, data from reports of daily intakes of sub-groups of phytonutrients in populations or sub-populations with longevity or reduced risk of chronic disease were compared and a representative daily intake was calculated for each sub-group of phytonutrients. The Reference Intake, measured in mg/100kcal was 20 calculated from the representative daily intake based on a 2000 kcal per day diet.
WO 2006/053379 PCT/AU2005/001741 24 Table 5 - Reference Intakes Phytonutrient Average Intakes/Reference Intakes Reference Flavonoids Flavonols Average Intakes 5 Denmark: 15-30 mg/d Dragsted et al. (1997) Finland: 4 mg/d Knekt et al. (2000) Japan: 16 mg/d (women) Arai et al. (2000) USA: 20-22 mg/d Sampson et al. (2002) USA: 20 mg/d Rimm et al. (1996) 10 (middle-aged to older men) Reference Intakes (2000 kcal/d) 20 Dg/d (- 1 mg/ 100 k(al)1 Flavanols Estimated Daily Intakes 15 USA: 5K0-70 mg/d Gu et al. (2004) Netherlands: 72 mgld Arts et al. (2001) Reference Intakes (2000 kcal(d) Proanthocyanins (food extract) Bagchi et al. (2003) 160 mg/d (-8 rng/100 kcal 20 Anthocyanidins Estimated Daily Intakes Acceptable Daily intake (ADD) Clifford (2000a) 150-175 mg/d Reference Intake (2000 kcal/d) 25 150-175 mg/d (-8 mg/i00 kcal) Clifford (2000a) Carotenoids Provitamin A Estimated Daily Intakes hydrocarbon 30 USA: 2.2 mgd Chung-Ahuja et al. (1993) USA: 3.8 mg/d Forman et al. (1993) Australia: 4.4 mgld Wahlqvist et al. (1994) Australia: 7.0 mgld (Anglo-Celts) Wattanapenpaiboon (1995) Reference Intakes (2000 kcal/d) 35 1-2 mg/d Scientific Committee on Food m100 mgot il kcal under the European Commission (Sep 2000) WO 2006/053379 PCT/AU2005/001741 25 The Reference Intakes calculated above, in addition to other Reference intakes, are used in the following examples. EXAMPLE 2 - Apple (fresh produce) The types and amounts of sub-groups of phytonutrients present in 100g of raw apple, 5 including the skin of the apple, were determined and calculated. The phytonutrient density (mg/100kcal) of the apple was then calculated based on the amount of each identified sub-group of phytonutrients contained in the 100g, given that 100g of raw apple contained 52 kcal. The percentage of the RI was then calculated for each phytonutrient sub-group. 10 The results of example 2 are summarised in Tables 6 and 7. Table 6 - Phytonutrient analysis of 1Og of raw apple, including the skin of the apple Phytonutrient Phytonutrient Per 100g Per 100 Rls per % Rls Variety Group Sub-group kcal 100 kcal 52 kcal 192 g Flavonoids Flavonols 4.4 mg 8.5 mg 1 mg >100 4 Flavanols 9.1 mg 17.5 mg 8 mg >100 4 Carotenoids Provitamin A 27 p.g 52 ipg 100 pg 52 4 hydrocarbons Hydroxy carotenes 40 pg 77 pg 100 pgg 77 4 Miscellaneous Betaine 0.1 mg 0.2 mg 300 mg 0 WO 2006/053379 PCT/AU2005/001741 26 Table 7 - Score for 100g of raw apple, including the skin of the apple Component Component Score description 1 Flavonoids 25 2 Carotenoids 19 3 Miscellaneous 0 4 Variety 4 5 Integrity 10 Total 58 The component I to 3 scores were proportionately assigned based on the percentage RI of the sub-group having the highest percentage RI. In this example, the score for the 5 carotenoid group was calculated based on the percentage RI of the hydroxy carotene sub-group alone, 19 being 77% of the possible total of 25. The variety score (component 4) was determined by summing the number of phytonutrient sub-groups having a value of greater than 5% of the RI for that phytonutrient sub-group. 10 As the apple is fresh produce, the integrity score (component 5) is the maximum score available. EXAMPLE 3 - Salad vegetables The calculations and determinations described in example 2 were conducted on 1 Og of salad vegetables having the following approximate portions: 15 Lettuce 40 g Celery 20 g Asparagus 15 g Avocado log Cucumber 15 g WO 2006/053379 PCT/AU2005/001741 27 The results of example 3 are summarised in Tables 8 and 9. Table 8 - Phytonutrient analysis of 1Og of salad vegetables Phytonutrient Phytonutrient Per 100g Per 100 Rls per % Rls Variety Group Sub-group kcal 100 kcal 30 kcal 333 g Flavonoids Flavonols 1.8 mg 6 mg 1 mg >100 1 Flavones 1.4 mg 4.7 mg 50 pg >100 1 Flavanols 0.1 mg 0.3 mg 8 mg 4 Carotenoids Provitamin A 254 ptg 847 [ig 100 jig >100 1 hydrocarbons Hydroxy carotenes 312 ig 1000 jig 100 ig >100 1 Miscellaneous Betaine 0.2 mg 0.7 mg 300 mg 0 Table 9 - Score for 1OOg of salad vegetables Component Component Score description 1 Flavonoids 25 2 Carotenoids 25 3 Miscellaneous 0 4 Variety 4 5 Integrity 10 Total 64 5 As the percentage RI for the flavanol sub-group was less than that of the flavonol and flavone sub-groups, it was disregarded when assigning the score for the flavonoid group. Of the flavonoid sub-groups identified in the salad vegetables, the percentage RI of the 10 flavanols, 4%, indicated that the flavanols did not contribute substantially to meeting the WO 2006/053379 PCT/AU2005/001741 28 flavonoid group (component 1) requirement. Accordingly, the flavanol sub-group was not counted in the determination of the variety score. Again, the integrity score assigned to the salad vegetables was the maximum score available as the salad vegetables had not undergone any processing steps which 5 diminished the phytonutrient integrity of the salad vegetables. EXAMPLE 4 - Ready-to-Eat soup (70% vegetables) The calculations and determinations described in example 2 were conducted on 1O0g of ready-to-eat soup containing 70% vegetables, the vegetables having the following approximate proportions: 10 Carrots 15g Potatoes 40 g Pumpkins 10 g Onions 3 g Capsicums 2 g 15 The results of example 4 are summarised in Tables 10 and 11. Table 10 - Phytonutrient analysis of 100g of ready-to-eat soup Phytonutrient Phytonutrient Per 100g Per 100 Ris per % Rls Variety Group Sub-group kcal 100 kcal 45 kcal 222 g Flavonoids Flavonols 0.6 mg 1.3 mg 1 mg >100 1 Flavones 10 pig 20 pg 50 jg 40 Carotenoids Provitamin A 2.1 mg 4.7 mg 0.1 mg >100 I hydrocarbons Hydroxy carotenes 400 pig 900 pig 100 pg >100 j Miscellaneous Betaine 0.1 mg 0.2 mg 300 mg 0 WO 2006/053379 PCT/AU2005/001741 29 Table 11 - Score for 1Og of ready-to-eat soup Component Component Score description I Flavonoids 25 2 Carotenoids 25 3 Miscellaneous 0 4 Variety 4 5 Integrity 10 Total 64 As the percentage RI of the flavonol sub-group was higher than that of the flavone sub group, it was used as the basis for assigning the flavonoid group score. 5 As each sub-group had greater than 5% RI, all four sub-groups were counted toward the variety score. Again, the integrity score assigned to the ready-to-eat soup was the maximum score available as no processing steps which diminished the phytonutrient integrity of the vegetables had been undergone by the food. 10 EXAMPLE 5 - Flavoured (dairy and soy) drink The calculations and determinations described in example 2 were conducted on 1Og of flavoured (dairy and soy) drink having the following approximate proportions of ingredients: Non-fat milk 98 g 15 Soy isoflavones 15.7 mg Nutrifood@ Wild berries 1.3 g (see www.nutrifood.com for more details) The results of example 5 are summarised in Tables 12 and 13.
WO 2006/053379 PCT/AU2005/001741 30 Table 12 - Phytonutrient analysis of 1Og of flavoured (dairy and soy) drink Phytonutrient Phytonutrient Per 100g Per 100 Rls per % Ris Variety Group Sub-group kcal 100 kcal 35 kcal 286 g Flavonoids Isoflavones 15.7 mg 45 mg 3 mg >100 4 Anthocyanins* 160 mg 457 mg 8 mg >100 4 Carotenoids Provitamin A 32 jig 91 pLg 100 [ig 91 4 hydrocarbons Hydroxy carotenes 80 jg 229 jig 100 jig >100 4 * Mazza G, Miniati E. Anthocyanins in Fruits, Vegetables, and Grains. CRC Press, Florida, USA, 993. Table 13 - Score for 1Og of flavoured (dairy and soy) drink Component Component Score description 1 Flavonoids 25 2 Carotenoids 25 3 Miscellaneous 0 4 Variety 4 5 Integrity 0 Total 54 5 The integrity score assigned to the milk drink was the minimum score available due to the high number of processing steps the product was subjected to which diminished the phytonutrient integrity of the drink. It will be understood that the invention disclosed and defined in this specification 10 extends to all alternative combinations of two or more of the individual features mentioned or evident from the text or drawings. All of these different combinations constitute various alternative aspects of the invention.
WO 2006/053379 PCT/AU2005/001741 31 Reference to any prior art in the specification is not, and should not be taken as, an acknowledgement or any form of suggestion that this prior art forms part of the common general knowledge in Australia or any other jurisdiction or that this prior art could be reasonably be expected to be ascertained, understood and regarded as relevant by a 5 person skilled in the art.
Claims (56)
1. A nutraceutical composition including one or more extracts of one or more plant components, the one or more extracts providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value 5 predetermined to provide a therapeutically or prophylactically desirable effect.
2. A nutraceutical composition according to claim 1 including an effective amount of phytonutrient materials selected from the group consisting of flavonols, flavones, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, 10 hydroxycarotenoids, glucosinolates, allium organosulphur compounds, phytosterols, monoterpenes, hydroxycinnamates, phenolic acids, stilbenes, choline derivatives, or a combination thereof.
3. A nutraceutical composition according to claim 1, wherein the minimum value is about 25. 15
4. A nutraceutical composition according to claim 1, wherein the composition further includes one or more secondary nutraceutical components active nutritionally and/or therapeutically.
5. A nutraceutical composition according to claim 4, wherein the secondary nutraceutical component is selected from one or more of vitamins, minerals, 20 saccharides and/or other carbohydrates, fats, other nutritional supplements, hormones and pharmaceuticals.
6. A nutraceutical composition according to claim 4, wherein the secondary nutraceutical component is present in an amount from approximately 0.05% to 50% by weight, based on the total weight of the pharmaceutical composition. 25
7. A nutraceutical composition according to claim 6, wherein the secondary nutraceutical component is present in an amount of from approximately 1% to 40%, based on the total weight of the pharmaceutical composition. WO 2006/053379 PCT/AU2005/001741 33
8. A nutraceutical composition according to claim 1, wherein the nutraceutical composition further includes a pharmaceutically acceptable carrier or excipient.
9. A nutraceutical composition according to any one of claims 1, wherein the composition includes a source of monounsaturated fatty acids or a derivative 5 thereof.
10. A nutraceutical composition according to claim 9 wherein the edible oil is olive oil or red palm oil, or an extract thereof, or a mixture thereof.
11. A nutraceutical composition according to claim 9, wherein the source of monounsaturated fatty acids is present in an amount of from approximately 1 10 mgto25g.
12. A nutraceutical composition according to claim 11, wherein the source of monounsaturated fatty acids is present in an amount of from approximately 50 mg to 10 g.
13. A nutraceutical composition according to claim 1 including an extract from one 15 or more of leafy green vegetables, garlic, onion, leeks, apple, pear, dried fruits, or other food sources of the required phytonutrients, or a mixture thereof, with a source of monounsaturated fatty acids.
14. A nutraceutical composition according to claim 13, wherein the source of monounsaturated fatty acid is olive oil or red palm oil, an extract thereof or a 20 mixture thereof.
15. A nutraceutical composition according to claim 13, further including a nutraceutically acceptable carrier.
16. A nutraceutical composition according to claim 13, wherein the extract is present in an amount of from approximately 1% to 99% by weight, based on the 25 total weight of the composition. WO 2006/053379 PCT/AU2005/001741 34
17. A nutraceutical composition according to claim 16, wherein the extract is present in an amount of from approximately 5% to 75% by weight, based on the total weight of the composition.
18. A nutraceutical composition according to claim 17, wherein the extract is 5 present in an amount of from approximately 10% to 50% by weight, based on the total weight of the composition.
19. A cosmetic composition including one or more extracts of one or more plant components, the extracts providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value predetermined to 10 provide a therapeutically or prophylactically desirable effect.
20. A cosmetic composition according to claim 19 including an effective amount of phytonutrient materials selected from the group consisting of flavonols, flavones, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, 15 hydroxycarotenoids, glucosinolates, allium oganosulphur compounds, phytosterols, monoterpenes, hydroxycinnamates, phenolic acids, stilbenes, choline derivatives, or a combination thereof.
21. A cosmetic composition according to claim 19, wherein the minimum value is about 25. 20
22. A cosmetic composition according to claim 19, wherein the composition includes a source of monounsaturated fatty acids or a derivative thereof.
23. A cosmetic composition according to claim 22, wherein the source of monounsaturated fatty acids is olive oil or red palm oil, or an extract thereof, or a mixture thereof. 25
24. A cosmetic composition according to claim 23, wherein the source of monounsaturated fatty acids is present in an amount of from approximately 1 mg to 25 g. WO 2006/053379 PCT/AU2005/001741 35
25. A cosmetic composition according to claim 19, further including a pharmaceutically acceptable carrier or excipient.
26. A cosmetic composition according to claim 19 including an extract from one or more of leafy green vegetables, garlic, onion, leeks, apple, pear, dried fruits, or 5 other food sources of the required phytonutrients, or a mixture thereof, with a source of monounsaturated fatty acids.
27. A cosmetic composition according to claim 23, wherein the source of monounsaturated fatty acids is olive oil or red palm oil, an extract thereof or a mixture thereof. 10
28. A cosmetic composition according to claim 26, wherein the extract is present in an amount of from approximately 1% to 99% by weight, based on the total weight of the composition.
29. A cosmetic composition according to claim 24, wherein the extract is present in an amount of from approximately 5% to 75% by weight, based on the total 15 weight of the composition.
30. A cosmetic composition according to claim 19, further including one or more cosmetic additives.
31. A cosmetic composition according to claim 30, wherein the cosmetic additives may be selected from one or more of water-soluble or liposoluble dyes, fillers, 20 lipophilic or hydrophilic active agents, fragrances, additional carriers or excipients, lubricants, buffers, antibacterials, bulking agents, gelling agents, plasticisers, binding agents, antioxidants and stabilising agents.
32. A cosmetic composition according to claim 19, further including an active agent.
33. A cosmetic composition according to claim 32, wherein the active agent is 25 selected from one or more of the group consisting of hydrating agents, UV WO 2006/053379 PCT/AU2005/001741 36 screening agents, depigmenting agents, bleaching agents and tensioning agents.
34. A modified food composition including a nutraceutical composition including one or more extracts of one or more plant components, the one or more extracts 5 providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value predetermined to provide a therapeutically or prophylactically desirable effect.
35. A modified food composition according to claim 34 including an effective amount of phytonutrient materials selected from the group consisting of 10 flavonols, flavones, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates, allium organosulphur compounds, phytosterols, monoterpenes, hydroxycinnamates, phenolic acids, stilbenes, choline derivatives, or a combination thereof. 15
36. A modified food composition according to claim 34, wherein the minimum value is about 25.
37. A modified food composition according to claim 34, wherein the composition further includes one or more secondary nutraceutical components active nutritionally and/or therapeutically. 20
38. A modified food composition according to claim 37, wherein the secondary nutraceutical component is selected from one or more of vitamins, minerals, saccharides and/or other carbohydrates, fats, other nutritional supplements, hormones and pharmaceuticals.
39. A modified food composition according to claim 38, wherein the secondary 25 nutraceutical component is present in an amount from approximately 0.05% to 50% by weight, based on the total weight of the pharmaceutical composition. WO 2006/053379 PCT/AU2005/001741 37
40. A modified food composition according to claim 34, wherein the composition includes a source of monounsaturated fatty acids or a derivative thereof.
41. A modified food composition according to claim 40, wherein the source of monounsaturated fatty acids is present in an amount of from approximately 1 5 mg to 25 g.
42. A modified food composition according to claim 34 including an extract from one or more of leafy green vegetables, garlic, onion, leeks, apple, pear, dried fruits, or other food sources of the required phytonutrients, or a mixture thereof, with a source of monounsaturated fatty acids. 10
43. A modified food composition according to claim 42, wherein the extract is present in an amount of from approximately 1% to 99% by weight, based on the total weight of the composition.
44. A method of prophylactically or therapeutically treating a disease or degenerative effect which method includes administering to a human a 15 composition including one or more extracts providing a combination of phytonutrient materials, the type and amount of which are in excess of a minimum value predetermined to provide a therapeutically or prophylactically desirable effect.
45. A method according to claim 44 including an effective amount of phytonutrient 20 materials selected from the group consisting of flavonols, flavones, anthocyanidins, flavanones, chalcones, dichalcones, isoflavones, provitamin A hydrocarbon carotenoids, non-provitamin A carotenoids, hydroxycarotenoids, glucosinolates, allium organosulphur compounds, phytosterols, monoterpenes, hydroxycinnamates, phenolic acids, stilbenes, choline derivatives, or a 25 combination thereof.
46. A method according to claim 44, wherein the method is used to prophylactically or therapeutically treat skin ageing, skin health, skin deterioration, skin WO 2006/053379 PCT/AU2005/001741 38 conditions, cancer, cardiovascular disease, Alzheimer's disease, bone and joint diseases including osteoporosis and arthritis, obstructive airways diseases, including asthma, allergic conditions, conditions affecting the gastrointestinal tract, autoimmune diseases, and diabetes.. 5
47. A method of determining the nutritional value of a nutraceutical composition and applying a phytonutrient nutritional score thereto which method includes: (a) determining a nutritional characteristic(s) of the nutraceutical composition, the nutritional characteristics including phytonutrient content, phytonutrient variety and phytonutrient integrity of the food substance; 10 (b) correlating the nutritional characteristic(s) with a predetermined value range(s); and (c) summing the correlated nutritional characteristics to derive a phytonutrient nutritional score indicative of the nutritional value of the nutraceutical composition. 15
48. A method of determining the nutritional value of a food composition and applying a phytonutrient nutritional score thereto which method includes: (a) determining a nutritional characteristic(s) of the food substance, the nutritional characteristics including phytonutrient content, phytonutrient variety and phytonutrient integrity of the food substance; 20 (b) correlating the nutritional characteristic(s) with a predetermined value range(s); and (c) summing the correlated nutritional characteristics to derive a phytonutrient nutritional score indicative of the nutritional value of the food substance. WO 2006/053379 PCT/AU2005/001741 39
49. A method of controlling the nutritional value of a nutraceutical composition consumed by an individual, which method includes: (a) determining the phytonutrient nutritional score of a nutraceutical composition using a method according to claim 47; and 5 (b) modifying the nutritional value of a nutraceutical composition by incorporating an additive into the food substance.
50. A method of controlling the nutritional value of a food composition consumed by an individual, which method includes: (a) determining the phytonutrient nutritional score of a food substance using 10 a method according to claim 48; and (b) modifying the nutritional value of a food substance by incorporating an additive into the food substance.
51. A computer useable medium for determining the nutritional value of a nutraceutical composition including: 15 (a) means for determining nutritional components of the nutraceutical composition, the nutritional components, phytonutrient variety and phytonutrient integrity of nutraceutical composition; (b) means for correlating the nutritional components to predetermined value ranges; 20 (c) means for summing the correlated nutritional components to derive a phytonutrient score indicative of the nutritional value of the nutraceutical composition; and (d) means for displaying the phytonutrient nutritional score. WO 2006/053379 PCT/AU2005/001741 40
52. A computer useable medium for determining the nutritional value of a food composition including: (a) means for determining nutritional components of the food substance, the nutritional components, phytonutrient variety and phytonutrient integrity 5 of the food substance; (b) means for correlating the nutritional components to predetermined value ranges; (c) means for summing the correlated nutritional components to derive a phytonutrient score indicative of the nutritional value of the food 10 substance; and (d) means for displaying the phytonutrient nutritional score.
53. A computer useable medium for determining the nutritional value of a cosmetic composition including: (a) means for determining nutritional components of the food substance, the 15 nutritional components, phytonutrient variety and phytonutrient integrity of the food substance; (b) means for correlating the nutritional components to predetermined value ranges; (c) means for summing the correlated nutritional components to derive a 20 phytonutrient score indicative of the nutritional value of the food substance; and (d) means for displaying the phytonutrient nutritional score. WO 2006/053379 PCT/AU2005/001741 41
54. A method according to claim 51, wherein the computer usable medium is arranged to provide, as an output, a phytonutrient nutritional score and/or a list of any phytonutrient nutritional scores.
55. A method according to claim 52, wherein the computer usable medium is 5 arranged to provide, as an output, a phytonutrient nutritional score and/or a list of any phytonutrient nutritional scores.
56. A method according to claim 53, wherein the computer usable medium is arranged to provide, as an output, a phytonutrient nutritional score and/or a list of any phytonutrient nutritional scores.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2005306575A AU2005306575A1 (en) | 2004-11-16 | 2005-11-16 | Improved nutraceutical composition |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2004906558A AU2004906558A0 (en) | 2004-11-16 | Nutraceutical composition (3) | |
| AU2004906558 | 2004-11-16 | ||
| AU2005900508A AU2005900508A0 (en) | 2005-02-04 | Improved nutraceutical composition | |
| AU2005900508 | 2005-02-04 | ||
| AU2005306575A AU2005306575A1 (en) | 2004-11-16 | 2005-11-16 | Improved nutraceutical composition |
| PCT/AU2005/001741 WO2006053379A1 (en) | 2004-11-16 | 2005-11-16 | Improved nutraceutical composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2005306575A2 AU2005306575A2 (en) | 2006-05-26 |
| AU2005306575A1 true AU2005306575A1 (en) | 2006-05-26 |
Family
ID=38157583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2005306575A Abandoned AU2005306575A1 (en) | 2004-11-16 | 2005-11-16 | Improved nutraceutical composition |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2005306575A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110063458B (en) * | 2019-04-30 | 2022-05-31 | 仲恺农业工程学院 | A kind of preparation method of plum braised pomelo peel sausage |
-
2005
- 2005-11-16 AU AU2005306575A patent/AU2005306575A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005306575A2 (en) | 2006-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dixit et al. | Functional foods: exploring the health benefits of bioactive compounds from plant and animal sources | |
| Gupta et al. | Functional food with some health benefits, so called superfood: a review | |
| Drabińska et al. | Broccoli by-products improve the nutraceutical potential of gluten-free mini sponge cakes | |
| Yahia et al. | The contribution of fruit and vegetable consumption to human health | |
| Sidhu et al. | Bioactive compounds in banana fruits and their health benefits | |
| Tripathi et al. | Estimates for world population and global food availability for global health | |
| Swami et al. | Jackfruit and its many functional components as related to human health: a review | |
| Vayalil | Date fruits (Phoenix dactylifera Linn): an emerging medicinal food | |
| Liu | Potential synergy of phytochemicals in cancer prevention: mechanism of action | |
| Hui et al. | Handbook of vegetable preservation and processing | |
| Liu | Health-promoting components of fruits and vegetables in the diet | |
| US8591964B2 (en) | Vaccinium species compositions | |
| Denny et al. | Plant foods and health: focus on plant bioactives | |
| Resende et al. | Flours based on exotic fruits and their processing residues—features and potential applications to health and disease prevention | |
| Sawicka et al. | Nutraceuticals in food and pharmacy. A Review | |
| Fardet | New concepts and paradigms for the protective effects of plant-based food components in relation to food complexity | |
| Sharma et al. | Bioavailability of nutrients and safety measurements | |
| Goñi et al. | By-products from plant foods are sources of dietary fibre and antioxidants | |
| Singh | Bioactive nutrients in vegetables for human nutrition and health | |
| Tsegay et al. | Nutritional qualities and valorization trends of vegetable and fruit byproducts: a comprehensive review | |
| Kalia et al. | Nutritional enhancement of vegetable crops (with major emphasis on Broccoli: a new cole crop in India) | |
| Naseri | Nutritional and Bioactive Compounds of Bok-choy: Beneficial Effects on Human Health | |
| Turturică et al. | Carrot–Application in food industry and health benefits–review | |
| WO2006053379A1 (en) | Improved nutraceutical composition | |
| Wahlqvist et al. | Phytonutrients as Bioactive Food Components |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 16 MAY 2007 |
|
| MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |